Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1956 1
1957 5
1958 5
1959 1
1960 1
1961 3
1962 2
1963 2
1964 2
1968 1
1971 1
1972 2
1973 4
1974 2
1975 7
1976 4
1977 2
1978 5
1979 6
1980 5
1981 7
1982 4
1983 10
1984 5
1985 8
1986 10
1987 6
1988 12
1989 11
1990 6
1991 18
1992 20
1993 33
1994 43
1995 33
1996 34
1997 27
1998 23
1999 34
2000 43
2001 31
2002 28
2003 23
2004 30
2005 23
2006 31
2007 29
2008 40
2009 32
2010 35
2011 46
2012 27
2013 31
2014 51
2015 36
2016 49
2017 43
2018 42
2019 39
2020 55
2021 69
2022 61
2023 44
2024 48
2025 57
2026 23

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,362 results

Results by year

Filters applied: . Clear all
Page 1
X-Linked Agammaglobulinemia.
Smith CIE, Berglöf A. Smith CIE, et al. 2001 Apr 5 [updated 2024 Jun 27]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026. 2001 Apr 5 [updated 2024 Jun 27]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026. PMID: 20301626 Free Books & Documents. Review.
CLINICAL CHARACTERISTICS: X-linked agammaglobulinemia (XLA) is characterized by recurrent bacterial infections in affected males in the first two years of life. ...
CLINICAL CHARACTERISTICS: X-linked agammaglobulinemia (XLA) is characterized by recurrent bacterial infections in affec …
Agammaglobulinemia: from X-linked to Autosomal Forms of Disease.
Cardenas-Morales M, Hernandez-Trujillo VP. Cardenas-Morales M, et al. Clin Rev Allergy Immunol. 2022 Aug;63(1):22-35. doi: 10.1007/s12016-021-08870-5. Epub 2021 Jul 9. Clin Rev Allergy Immunol. 2022. PMID: 34241796 Free PMC article. Review.
While the most common cause of congenital agammaglobulinemia is X-linked agammaglobulinemia (XLA), accounting for approximately 85% of cases, other genetic forms of agammaglobulinemia have been identified. ...
While the most common cause of congenital agammaglobulinemia is X-linked agammaglobulinemia (XLA), accounting for appro …
X-linked Agammaglobulinemia.
Suri D, Rawat A, Singh S. Suri D, et al. Indian J Pediatr. 2016 Apr;83(4):331-7. doi: 10.1007/s12098-015-2024-8. Epub 2016 Feb 24. Indian J Pediatr. 2016. PMID: 26909497 Review.
X-linked agammaglobulinemia (XLA) is one of the commonest primary immune deficiencies encountered in pediatric clinical practice. ...
X-linked agammaglobulinemia (XLA) is one of the commonest primary immune deficiencies encountered in pediatric clinical …
X-Linked Agammaglobulinemia and COVID-19: Two Case Reports and Review of Literature.
Devassikutty FM, Jain A, Edavazhippurath A, Joseph MC, Peedikayil MMT, Scaria V, Sandhya P, Govindaraj GM. Devassikutty FM, et al. Pediatr Allergy Immunol Pulmonol. 2021 Sep;34(3):115-118. doi: 10.1089/ped.2021.0002. Pediatr Allergy Immunol Pulmonol. 2021. PMID: 34495748 Free PMC article. Review.
Introduction: The Centers for Disease Control and Prevention (CDC) has listed primary immunodeficiency disorders as being predisposed to severe coronavirus disease 2019 (COVID-19). However, patients affected with X-linked agammaglobulinemia (XLA) have shown c …
Introduction: The Centers for Disease Control and Prevention (CDC) has listed primary immunodeficiency disorders as being predisposed to sev …
X-Linked Agammaglobulinemia with Kawasaki Disease.
Shakya S, Maheshwari A, Divya K, Katti BR, R A, Mahto D. Shakya S, et al. Indian J Pediatr. 2022 Apr;89(4):413. doi: 10.1007/s12098-021-04058-z. Epub 2022 Jan 11. Indian J Pediatr. 2022. PMID: 35013980 No abstract available.
COVID-19 and X-linked agammaglobulinemia (XLA) - insights from a monogenic antibody deficiency.
Ponsford MJ, Shillitoe BMJ, Humphreys IR, Gennery AR, Jolles S. Ponsford MJ, et al. Curr Opin Allergy Clin Immunol. 2021 Dec 1;21(6):525-534. doi: 10.1097/ACI.0000000000000792. Curr Opin Allergy Clin Immunol. 2021. PMID: 34596095 Review.
This review summarizes the lessons learned from COVID-19 infection in X-linked agammaglobulinemia (XLA) due to genetic defects in Bruton's tyrosine kinase (BTK). ...
This review summarizes the lessons learned from COVID-19 infection in X-linked agammaglobulinemia (XLA) due to genetic …
Crohn's-like Enteritis in X-Linked Agammaglobulinemia: A Case Series and Systematic Review.
Khan F, Person H, Dekio F, Ogawa M, Ho HE, Dunkin D, Secord E, Cunningham-Rundles C, Ward SC. Khan F, et al. J Allergy Clin Immunol Pract. 2021 Sep;9(9):3466-3478. doi: 10.1016/j.jaip.2021.04.070. Epub 2021 May 21. J Allergy Clin Immunol Pract. 2021. PMID: 34029777 Free PMC article.
BACKGROUND: X-linked agammaglobulinemia (XLA) is an inherited primary immunodeficiency that usually manifests clinically with recurrent sinopulmonary infections. ...
BACKGROUND: X-linked agammaglobulinemia (XLA) is an inherited primary immunodeficiency that usually manifests clinicall …
An International Survey of Allogeneic Hematopoietic Cell Transplantation for X-Linked Agammaglobulinemia.
Nishimura A, Uppuluri R, Raj R, Swaminathan VV, Cheng Y, Abu-Arja RF, Fu B, Laberko A, Albert MH, Hauck F, Bucciol G, Bigley V, Elcombe S, Kharya G, Pronk CJH, Wehr C, Neven B, Warnatz K, Meyts I, Morio T, Gennery AR, Kanegane H. Nishimura A, et al. J Clin Immunol. 2023 Nov;43(8):1827-1839. doi: 10.1007/s10875-023-01551-2. Epub 2023 Jul 16. J Clin Immunol. 2023. PMID: 37454339 Review.
PURPOSE: X-linked agammaglobulinemia (XLA) is an inborn error of immunity caused by variants in Bruton's tyrosine kinase (BTK). ...
PURPOSE: X-linked agammaglobulinemia (XLA) is an inborn error of immunity caused by variants in Bruton's tyrosine kinas …
X-Linked Agammaglobulinemia: Infection Frequency and Infection-Related Mortality in the USIDNET Registry.
O'Toole D, Groth D, Wright H, Bonilla FA, Fuleihan RL, Cunningham-Rundles C, Sullivan KE, Ochs HD, Marsh R, Feuille E. O'Toole D, et al. J Clin Immunol. 2022 May;42(4):827-836. doi: 10.1007/s10875-022-01237-1. Epub 2022 Mar 15. J Clin Immunol. 2022. PMID: 35288819 Free PMC article.
X-linked agammaglobulinemia (XLA) is a primary immunodeficiency disorder caused by mutations in the Bruton tyrosine kinase (BTK) gene leading to B lymphocyte deficiency and susceptibility to infection. ...
X-linked agammaglobulinemia (XLA) is a primary immunodeficiency disorder caused by mutations in the Bruton tyrosine kin …
1,362 results